Larson Financial Group’s Pulmonx LUNG Stock Holding History

Larson Financial Group’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-36	Closed	-$242	–	3409
2025 Q1	$242	Buy	+36	New	+$255	﹤0.01%	2746

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Larson Financial Group's LUNG Position: Q2 2025 in Review

Larson Financial Group sold out of Pulmonx (LUNG) in Q2 2025, closing a stake of 36 shares — an estimated $242 sold.

Larson Financial Group first reported a position in LUNG in Q1 2025 and held it in 1 quarter. The position peaked at $242 in Q1 2025. 113 funds tracked by Wall St. Rank hold LUNG as of Q2 2025.

Larson Financial Group reported no remaining Pulmonx position as of Q2 2025 after selling out during the quarter.
Larson Financial Group sold 36 Pulmonx shares in Q2 2025, an estimated $242.
Larson Financial Group first reported a position in Pulmonx in Q1 2025 and held it in 1 quarter.
Larson Financial Group's Pulmonx position peaked at $242 in Q1 2025.
113 funds tracked by Wall St. Rank held Pulmonx as of Q2 2025.

Based on Larson Financial Group's 13F filing for Q2 2025, filed 8 Aug 2025.